National Rapid TLC: Testing and Linkage to Care

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorUnity Health Toronto

About this trial

The goal of this cross-sectional study is to learn if the GeneXpert system is a practical system for HIV and STBBI testing in community-based organizations and health clinics. The study involves a clinical trial to learn if the HIV-1 Qual XC test works to identify HIV in near-patient settings. The main questions it aims to answer are to create a near-patient testing model for testing and treating patients in a single visit, and to learn if the HIV-1 Qual XC test works to accurately detect HIV in patients. Patients who come to study sites to ask for HIV or STBBI testing will be given the option to participate in the study. Those who agree with provide samples for the tests of their choice and answer survey questions before and after their tests are completed. Those who participate in the clinical trial will have a blood sample sent to provincial labs to compare the results to the HIV -1 Qual XC test. Follow-up visits will be done at 1,3 and 6 months to see if patients completed treatment and/or remained connected to care.

Eligibility criteria

Qualifiers

Individuals accessing STBBI testing at specific locations who are ≥ 16 years of age

Able to provide informed consent.

Disqualifiers

Unable to provide signed informed consent (e.g., intoxicated)

In the opinion of the site PI /study operator, the participant is unable to complete the study elements.

Participants who have previously enrolled in the study.

Trial design

Treatments tested in this trial

  • Xpert® HIV-1 Qual XC

Treatment groups

2,500 Participants
are divided into 1 treatment group

Sponsors and collaborators